MamtaK(Khandelwal)JainMD

Clinical Trials

• Prospective Observational Epidemiologic Study of Maraviroc's Safety Start of enrollment: 2008 Mar 31

  Completed

• Long-term Observational Study in HIV Subjects Exposed to EGRIFTA® Start of enrollment: 2013 Feb 01

  Terminated

• Diabetic Retinopathy in HIV Subjects Treated With EGRIFTA® Start of enrollment: 2012 Jun 01

  Terminated

  Phase 4

• HBV-HIV Coinfection Research Network Start of enrollment: 2014 Apr 01

  Completed

• Study to Evaluate Efficacy and Safety of Darunavir/Cobicistat/Emtricitabine/Tenofovir Alafenamide (D/C/F/TAF) Regimen Versus Boosted Protease Inhibitor (bPI) Along With Emtricitabine/Tenofovir Disoproxil Fumarate (FTC/TDF) Regimen in Virologically-Suppressed, HIV-1 Infected Participants Start of enrollment: 2015 Mar 01

  Completed

  Phase 3

• Evaluating the Safety and Efficacy of Anti-Influenza Intravenous Hyperimmune Immunoglobulin (IVIG) in Adults Hospitalized With Influenza Start of enrollment: 2015 Jan 01

  Completed

  Phase 3

• Evaluating the Use of Pitavastatin to Reduce the Risk of Cardiovascular Disease in HIV-Infected Adults Start of enrollment: 2015 Mar 26

  Completed

  Phase 3

• Attachment Inhibitor Comparison in Heavily Treatment Experienced Patients Start of enrollment: 2015 Feb 23

  Active, not recruiting

  Phase 3

• Safety and Efficacy of a Switch to Doravirine, Tenofovir, Lamivudine (MK-1439A) in Human Immunodeficiency Virus (HIV-1)-Infected Participants Virologically Suppressed on an Anti-retroviral Regimen in Combination With Two Nucleoside Reverse Transcriptase Inhibitors (MK-1439A-024) Start of enrollment: 2015 Jun 09

  Completed

  Phase 3

• Comparing the Efficacy and Safety of High-Titer Versus Low-Titer Anti-Influenza Immune Plasma for the Treatment of Severe Influenza A Start of enrollment: 2015 Nov 01

  Completed

  Phase 3

• Study to Evaluate the Safety and Efficacy of Bictegravir/Emtricitabine/Tenofovir Alafenamide Versus Abacavir/Dolutegravir/Lamivudine in Human Immunodeficiency Virus-1 (HIV-1) Infected, Antiretroviral Treatment-Naive Adults Start of enrollment: 2015 Nov 13

  Completed

  Phase 3

• Study to Evaluate the Safety and Efficacy of Bictegravir/Emtricitabine/Tenofovir Alafenamide Versus Dolutegravir + Emtricitabine/Tenofovir Alafenamide in Human Immunodeficiency Virus (HIV-1) Infected, Antiretroviral Treatment-Naive Adults Start of enrollment: 2015 Nov 11

  Completed

  Phase 3

• Assessing Long-term CTN 0049 Outcomes, HCV Prevalence and Progression Along the HCV Care Continuum Among HIV/HCV Co-infected Substance Users in the U.S. Start of enrollment: 2015 Dec 01

  Completed

  Not Applicable

• Efficacy, Safety, and Tolerability of Ledipasvir/Sofosbuvir (LDV/SOF) Treatment for HIV/HCV Co-infected Participants Who Switch to Elvitegravir/Cobicistat/Emtricitabine/Tenofovir Alafenamide (E/C/F/TAF) or Emtricitabine/Rilpivirine/Tenofovir Alafenamide (F/R/TAF) Prior to LDV/SOF HCV Treatment Start of enrollment: 2016 Apr 01

  Completed

  Phase 3

• Atovaquone for Treatment of COVID-19 Start of enrollment: 2020 Jul 22

  Completed

  Phase 2

• Study of Hepatitis C Virus (HCV) Viral Kinetics in HIV/HCV and HCV Patients Start of enrollment: 2005 Sep 01

  Completed

• Outpatient Treatment With Anti-Coronavirus Immunoglobulin Start of enrollment: 2021 Aug 06

  Recruiting

  Phase 3

• Oral Hepatitis C Treatment for Indolent Lymphoma (OPTImaL) Study Start of enrollment: 2016 Feb 25

  Terminated

  Phase 4

• Study to Evaluate the Safety and Antiviral Activity of Remdesivir (GS-5734™) in Participants With Severe Coronavirus Disease (COVID-19) Start of enrollment: 2020 Mar 06

  Completed

  Phase 3

• Study to Evaluate the Safety and Antiviral Activity of Remdesivir (GS-5734™) in Participants With Moderate Coronavirus Disease (COVID-19) Compared to Standard of Care Treatment Start of enrollment: 2020 Mar 15

  Completed

  Phase 3

• Vaccination for Recovered Inpatients With COVID-19 (VATICO) Start of enrollment: 2021 Aug 25

  Completed

  Phase 4

• ACTIV-2: A Study for Outpatients With COVID-19 Start of enrollment: 2020 Aug 19

  Completed

  Phase 2, Phase 3

• Evaluation of the Efficacy and Safety of Sarilumab in Hospitalized Patients With COVID-19 Start of enrollment: 2020 Mar 18

  Completed

  Phase 2, Phase 3

• ACTIV-3: Therapeutics for Inpatients With COVID-19 Start of enrollment: 2020 Aug 04

  Completed

  Phase 3

• Inpatient Treatment of COVID-19 With Anti-Coronavirus Immunoglobulin (ITAC) Start of enrollment: 2020 Oct 08

  Completed

  Phase 3

• Adaptive COVID-19 Treatment Trial 4 (ACTT-4) Start of enrollment: 2020 Dec 02

  Completed

  Phase 3

• Adaptive COVID-19 Treatment Trial 3 (ACTT-3) Start of enrollment: 2020 Aug 05

  Completed

  Phase 3

• Adaptive COVID-19 Treatment Trial 2 (ACTT-2) Start of enrollment: 2020 May 08

  Completed

  Phase 3

• A Study to Evaluate the Efficacy and Safety of Pimodivir in Combination With the Standard-of-Care Treatment in Adolescent, Adult, and Elderly Non-Hospitalized Participants With Influenza A Infection Who Are at Risk of Developing Complications Start of enrollment: 2018 Jan 21

  Terminated

  Phase 3

• A Study to Evaluate the Efficacy and Safety of Pimodivir in Combination With the Standard-of-Care Treatment in Adolescent, Adult, and Elderly Hospitalized Participants With Influenza A Infection Start of enrollment: 2018 Jan 03

  Terminated

  Phase 3

• Join now to see all